Clinical Trial Update: Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating spatially fractionated radiotherapy in combination with immunotherapy for advanced solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Solid Cancers, Radiotherapy | Phase 2 | Status: RECRUITING